KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutrien (NTR) Cash & Equivalents (2016 - 2026)

Nutrien has reported Cash & Equivalents over the past 11 years, most recently at $777.0 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents fell 13.18% year-over-year to $777.0 million; the TTM value through Mar 2026 reached $777.0 million, down 13.18%, while the annual FY2025 figure was $701.0 million, 17.82% down from the prior year.
  • Cash & Equivalents for Q1 2026 was $777.0 million at Nutrien, up from $701.0 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $1.5 billion in Q1 2023 and troughed at $422.0 million in Q1 2024.
  • A 5-year average of $790.7 million and a median of $777.0 million in 2026 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: surged 169.78% in 2023 and later plummeted 71.35% in 2024.
  • Year by year, Cash & Equivalents stood at $901.0 million in 2022, then rose by 4.44% to $941.0 million in 2023, then fell by 9.35% to $853.0 million in 2024, then dropped by 17.82% to $701.0 million in 2025, then increased by 10.84% to $777.0 million in 2026.
  • Business Quant data shows Cash & Equivalents for NTR at $777.0 million in Q1 2026, $701.0 million in Q4 2025, and $514.0 million in Q3 2025.